Publication: 292

Publication: 292

CYP2D6 and HOXB13/IL17BR: Combining inherited and tumor gene markers for prediction of tamoxifen resistance

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Clin Cancer Res vol 14 (18) 5864-5868

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 664
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:

Pharmas:
Grants:: P30 CA015083-240001, CA116201, U-01 GM61388, R01 CA087898-01A2, CA 90628, R01 CA087898, U10 CA025224-28, K12 CA090628, CA-25224, U01 GM061388, K12 CA090628-05, U01 GM061388-07, P50 CA116201, P30 CA015083, P50 CA116201-01, U10 CA025224, CA 15083, N01 CA015083, CA87898

Corr. Author:
Authors:: Matthew P. Goetz Vera J. Suman Fergus J. Couch Matthew M. Ames James M. Rae Mark G. Erlander Xiao-Jun Ma Dennis C. Sgroi Carol A. Reynolds Wilma L. Lingle Richard M. Weinshilboum David A. Flockhart Zeruesenay Desta Edith A. Perez James N. Ingle

Networks:

Study: NCCTG-89-30-52
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Tamoxifen, Cytochrome P450 2D6, HOXB13/IL17BR, Breast cancer